SEER INC. - CLASS A COMMON STOCK

Seer Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Outlook

13 May 2025 13:05:00 By Nasdaq GlobeNewswire

Seer to Report First Quarter 2025 Financial Results on May 13, 2025

24 Apr 2025 13:05:00 By Nasdaq GlobeNewswire

Seer Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Outlook

27 Feb 2025 13:05:00 By Nasdaq GlobeNewswire

Seer to Participate in the TD Cowen 45th Annual Health Care Conference

21 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025

20 Feb 2025 04:00:00 By Nasdaq GlobeNewswire

Seer to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025

13 Feb 2025 13:15:10 By Nasdaq GlobeNewswire

Seer to Present at the J.P. Morgan 43rd Annual Healthcare Conference

02 Jan 2025 13:05:00 By Nasdaq GlobeNewswire

Seer Ranked Number 57 Fastest-Growing Company in North America on the 2024 Deloitte Technology Fast 500™

21 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

Seer to Participate in Upcoming November Investor Conferences

08 Nov 2024 04:00:08 By Nasdaq GlobeNewswire

Seer Reports Third Quarter 2024 Financial Results

06 Nov 2024 13:05:00 By Nasdaq GlobeNewswire

Seer Enters into a Co-Marketing and Sales Agreement with Thermo Fisher Scientific

06 Nov 2024 13:03:00 By Nasdaq GlobeNewswire

Seer Highlights Capability of Deep Proteomics to Enhance Genomic Insights Into Alzheimer’s, Lung Cancer, and More at ASHG 2024

31 Oct 2024 04:00:00 By Nasdaq GlobeNewswire

Seer Showcases Scalable Proteomic Advancements Impacting Alzheimer’s, Population Health, and Xenotransplantation at HUPO 2024

21 Oct 2024 04:00:00 By Nasdaq GlobeNewswire

Seer to Report Third Quarter 2024 Financial Results on November 6, 2024

17 Oct 2024 13:05:00 By Nasdaq GlobeNewswire

Seer to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference

22 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

Seer Appoints Nicolas Roelofs to its Board of Directors

14 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

Seer to Participate in the Canaccord Genuity 44th Annual Growth Conference

09 Aug 2024 04:00:53 By Nasdaq GlobeNewswire

Seer Reports Second Quarter 2024 Financial Results

08 Aug 2024 13:05:00 By Nasdaq GlobeNewswire

Seer to Report Second Quarter 2024 Financial Results on August 8, 2024

18 Jul 2024 13:03:00 By Nasdaq GlobeNewswire

Seer Proteograph™ Provides Differentiated Insights into Spaceflight Proteomic Alterations for Precision Medicine and Biomarker Discovery

11 Jun 2024 08:11:56 By Nasdaq GlobeNewswire